Views & Analysis | Perspectives on pharma industry issues

R&D

Why every healthcare breakthrough creates a new education ch...

Patients will only benefit from a health breakthrough if HCPs and the systems around them are able to put it into practice.

Sales & Marketing

Female HCP in her office on phone holding clipboard of patient information

Sponsored

Commercial Evidence: Turning field intelligence into actiona...

Agentic Call Reports help turn field observations into scalable, actionable insights generating Commercial Evidence.

Digital

Healthcare AI’s off switch needs a budget

An AI system can be cheap to buy and expensive to stop.

Patients

Union Jack on pill, one of many scattered on aqua surface

Rare diseases, real opportunity: Why the UK’s next challenge...

The UK has the science, the talent, and the investment. The next step is ensuring that innovation translates into timely patient impact.

Market Access

Chinese flag atop pills on black background

Is the next generation of Chinese biotech ready to go global...

Will Chinese biotechs continue to transfer most ex-China rights, or retain their strongest assets and compete internationally themselves?

Articles

Marketing rationales to avoid in 2011 (part II)

In the second of her two part series on marketing rationales, Andree Bates gives tips on how to make rational marketing decisions. All people, even marketers, are subject to irrationality. It's not a question of how smart you are, but of having evolved in an environment where impulsive actions kept us alive. Hunter-gatherers who…

Articles

Patients can inspire the industry to innovate

Can patient communities provide useful information directly to pharma and not just each other? Brian Loew, Founder of Inspire, explains to pharmaphorum how they can. As information becomes much more readily available and patients are able to connect with each other through social networks, many disease areas...

Articles

Medication packaging: an impact on patient adherence

The economic burden and medical complications associated with non compliance are huge. Here, Tassilo Korab discusses packaging, an aspect of non-compliance that receives little attention. A White Paper released 2010 by the Center for Health Transformation’s 21st Century Intelligent Pharmacy Project in the US states in its introduction: Non adherence is a tremendous problem…

Sales & Marketing

Sponsored

Commercial Evidence: Turning field intelligence into actiona...

Agentic Call Reports help turn field observations into scalable, actionable insights generating Commercial Evidence.

Sales & Marketing

The independent pharmacy opportunity pharma marketers are ov...

Pharma marketers often underestimate the value of independent pharmacies.

Digital

Healthcare AI’s off switch needs a budget

An AI system can be cheap to buy and expensive to stop.

Digital

Sponsored

AI-enabled pharmacovigilance, with Updesh Dosanjh

Updesh Dosanjh, IQVIA commercialisation lead for safety technology, discusses how and why the role of AI in pharmacovigilance is changing.

Market Access

Is the next generation of Chinese biotech ready to go global...

Will Chinese biotechs continue to transfer most ex-China rights, or retain their strongest assets and compete internationally themselves?

Market Access

Two business hands outstretched, one weighing cash, the other drugs, for balance

What the revised 340B rebate pilot programme means for pharm...

While the scope of the revised pilot is limited, it may be a harbinger for a broader policy shift.

Oncology

Australia, CAR-T therapy, and solid tumours

Bev Menner, chief executive officer at Cell Therapies Pty Ltd, discusses CAR-T therapies for solid tumours and Australian and APAC R&D more generally.

Oncology